Spencer Pharmaceutical Company Description

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases.

The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications.

It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.

Spencer Pharmaceutical Inc.

Country	United States
Founded	1998
Industry	Medical - Pharmaceuticals
Sector	Healthcare
Employees	2
CEO	Maximilien Arella

Contact Details

Address: 8 Faneuil Hall Marketplace Boston, Delaware 02109 United States
Phone	617-973-5017

Stock Details

Ticker Symbol	SPPH
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US8482241010
SIC Code	5122

Key Executives

Name	Position
Dr. Maximilien Arella	Chairman, Chief Executive Officer and President